Company Revenue

The company's revenue declined -7.4% in 3Q20 as capital sales remain slow, and the lack of team sports activity depresses...

The company grew +10% in 3Q20, driven by U.S. spinal implant sales strengthened by new product introductions and robotics pull-through....

Orthopedic procedure volumes improved more quickly than expected in the U.S., helping DePuy Synthes close 3Q20 down -2.6% compared to...

The company's exposure in global markets caused revenue declines of -24% in 1H20, but MicroPort launched several new products to...

The company grew in the high single digits for 1H20 as it benefited from provincial procurement tenders and the acquisition...

The company believes it outperformed peers and took at least half a point of share in the second calendar quarter...

Despite the impact of COVID, the company forged ahead with its priorities, including expanding its U.S. business and accelerating its...

The company's orthopedic sales declined -49% in 2Q20 but recovered significantly from -80% declines in April. Integra expects improvement through...

The company exited June down just -3% in its joint replacement business and expects sequential improvements to continue through 2020...

The company's sales improved throughout 2Q20 but exited June with declines in the mid-teens. Orthofix remains cautious about second-half unpredictability....